These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 14982578)

  • 1. Antithrombin and heparin may limit the activation of Protein C.
    Macias W; Yan SB
    Acta Anaesthesiol Scand; 2004 Mar; 48(3):385. PubMed ID: 14982578
    [No Abstract]   [Full Text] [Related]  

  • 2. Low utilisation of unactivated protein C in a patient with meningococcal septic shock and disseminated intravascular coagulation.
    Lignell A; Siegbahn A; Stridsberg M; Pauksen K; Gedeborg R; Sjölin J
    Acta Anaesthesiol Scand; 2003 Aug; 47(7):897-900. PubMed ID: 12859313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of anticoagulants in patients with sepsis.
    Langer M; Riccardi F; Piovella F; Klersy C
    JAMA; 2002 Jan 23-30; 287(4):448-9. PubMed ID: 11798358
    [No Abstract]   [Full Text] [Related]  

  • 4. Endotoxin induced coagulation activation and protein C reduction in meningococcal septic shock.
    Fijnvandraat K; Peters M; Derkx B; van Deventer S; ten Cate JW
    Prog Clin Biol Res; 1994; 388():247-54. PubMed ID: 7831362
    [No Abstract]   [Full Text] [Related]  

  • 5. Early treatment with activated protein C for meningococcal septic shock: case report and literature review.
    Hasin T; Leibowitz D; Rot D; Weiss Y; Chajek-Shaul T; Nir-Paz R
    Intensive Care Med; 2005 Jul; 31(7):1002-3. PubMed ID: 15905995
    [No Abstract]   [Full Text] [Related]  

  • 6. Comment on "Early treatment with activated protein C for meningococcal septic shock: case report and literature review" by Hasin et al.
    Thomas GL; Clark P
    Intensive Care Med; 2005 Dec; 31(12):1729; author reply 1730. PubMed ID: 16283165
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of anticoagulants and the role of thrombin on neutrophil-endothelial cell interactions in septic shock.
    Tsen A; Kirschenbaum LA; LaRow C; Khan R; Kurtz S; Bansal S; Astiz ME
    Shock; 2009 Feb; 31(2):120-4. PubMed ID: 18636042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Puerperal streptococcal toxic shock syndrome treated with recombinant human activated protein C and intravenous immunoglobulin.
    Al-Rawi S; Woodward LJ; Knight J
    Int J Obstet Anesth; 2009 Apr; 18(2):169-72. PubMed ID: 19195874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuing challenges of sepsis research.
    Crowther MA; Marshall JC
    JAMA; 2001 Oct; 286(15):1894-6. PubMed ID: 11597294
    [No Abstract]   [Full Text] [Related]  

  • 10. Activated protein C for the treatment of fulminant meningococcal septicaemia.
    Thomas GL; Wigmore T; Clark P
    Anaesth Intensive Care; 2004 Apr; 32(2):284-7. PubMed ID: 15957734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Activated protein C in sepsis].
    Brandtzaeg P
    Tidsskr Nor Laegeforen; 2004 Mar; 124(6):766. PubMed ID: 15039802
    [No Abstract]   [Full Text] [Related]  

  • 12. [Severe sepsis and septic shock: crossroad between inflammation and coagulation].
    Jiménez Ortiz JL; Labarta Monzón L; Armengol Sáez S
    Med Clin (Barc); 2002 Jan; 118(2):78. PubMed ID: 11809155
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pediatric septic shock--timing, volume resuscitation and anticoagulation therapy].
    Kjaergaard S; Goldinger MP; Højberg AS
    Ugeskr Laeger; 2006 Jan; 168(3):289-90. PubMed ID: 16430817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of recombinant activated protein C and low-dose heparin on neutrophil-endothelial cell interactions in septic shock.
    Kirschenbaum LA; Lopez WC; Ohrum P; Tsen A; Khazin J; Astiz ME
    Crit Care Med; 2006 Aug; 34(8):2207-12. PubMed ID: 16775572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Septic shock with hemorrhagic exanthema].
    Neureuther G; Luderschmidt C; Schwandt P
    Internist (Berl); 1983 Feb; 24(2):107-9. PubMed ID: 6341284
    [No Abstract]   [Full Text] [Related]  

  • 16. Meningococcal septicaemia: treatment with protein C concentrate.
    Clarke RC; Johnston JR; Mayne EE
    Intensive Care Med; 2000 Apr; 26(4):471-3. PubMed ID: 10872142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation in sepsis: is low-dose heparin as effective as activated protein C?
    Agarwal R; Gupta D
    Intensive Care Med; 2005 Sep; 31(9):1297-8. PubMed ID: 16007415
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of protein C concentrate in pediatric patients with sepsis.
    Silvani P; Camporesi A; Licari E; Wolfler A
    Minerva Anestesiol; 2005 Jun; 71(6):373-8. PubMed ID: 15886604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of pulmonary embolism in 2005.
    Davidson BL; Tomkowski WZ
    Dis Mon; 2005; 51(2-3):116-23. PubMed ID: 15900263
    [No Abstract]   [Full Text] [Related]  

  • 20. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.